Zoltán Herold

406 total citations
51 papers, 238 citations indexed

About

Zoltán Herold is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Zoltán Herold has authored 51 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 14 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Zoltán Herold's work include Inflammatory Biomarkers in Disease Prognosis (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Metabolism, Diabetes, and Cancer (7 papers). Zoltán Herold is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Metabolism, Diabetes, and Cancer (7 papers). Zoltán Herold collaborates with scholars based in Hungary, Germany and Austria. Zoltán Herold's co-authors include Anikó Somogyi, Magdolna Herold, Magdolna Dank, Attila Marcell Szász, Márton Doleschall, Attila Patócs, Klára Rosta, Péter Nagy, Zoltán Kukor and Dániel Sándor Veres and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Zoltán Herold

46 papers receiving 235 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zoltán Herold Hungary 9 76 63 59 32 30 51 238
Jihye Kim South Korea 12 62 0.8× 50 0.8× 98 1.7× 9 0.3× 22 0.7× 35 391
Isabel Anna Carota Germany 9 30 0.4× 64 1.0× 191 3.2× 15 0.5× 24 0.8× 10 321
Lijun Yang China 10 51 0.7× 58 0.9× 109 1.8× 19 0.6× 94 3.1× 25 350
Anna Synakiewicz Poland 10 112 1.5× 44 0.7× 73 1.2× 12 0.4× 10 0.3× 25 299
Yan‐Wen Shu China 7 35 0.5× 37 0.6× 79 1.3× 34 1.1× 95 3.2× 11 254
Quan Liu China 9 63 0.8× 62 1.0× 84 1.4× 25 0.8× 17 0.6× 45 260
Agathi Karakosta Greece 10 91 1.2× 72 1.1× 94 1.6× 14 0.4× 10 0.3× 23 257
David Cheung Canada 11 31 0.4× 62 1.0× 120 2.0× 21 0.7× 18 0.6× 21 314
Yanfei Ma United States 6 35 0.5× 66 1.0× 66 1.1× 26 0.8× 29 1.0× 8 247
Lucas Bacmeister Germany 6 50 0.7× 37 0.6× 175 3.0× 13 0.4× 61 2.0× 14 369

Countries citing papers authored by Zoltán Herold

Since Specialization
Citations

This map shows the geographic impact of Zoltán Herold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoltán Herold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoltán Herold more than expected).

Fields of papers citing papers by Zoltán Herold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoltán Herold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoltán Herold. The network helps show where Zoltán Herold may publish in the future.

Co-authorship network of co-authors of Zoltán Herold

This figure shows the co-authorship network connecting the top 25 collaborators of Zoltán Herold. A scholar is included among the top collaborators of Zoltán Herold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoltán Herold. Zoltán Herold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nyírő, Gábor, Ábel Decmann, Zoltán Herold, et al.. (2024). miRNA Expression Profiling in G1 and G2 Pancreatic Neuroendocrine Tumors. Cancers. 16(14). 2528–2528. 1 indexed citations
3.
Nyírő, Gábor, Zoltán Herold, János Tibor Fekete, et al.. (2024). Circulating miRNAs and Machine Learning for Lateralizing Primary Aldosteronism. Hypertension. 81(12). 2479–2488. 6 indexed citations
4.
Szentmártoni, Gyöngyvér, et al.. (2024). Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors. Biomedicines. 12(3). 593–593. 5 indexed citations
5.
Garay, Tamás, Magdolna Herold, Alexandra Simon, et al.. (2024). Immune Marker and C-Reactive Protein Dynamics and Their Prognostic Implications in Modulated Electro-Hyperthermia Treatment in Advanced Pancreatic Cancer: A Retrospective Analysis. SHILAP Revista de lepidopterología. 4(4). 385–399. 1 indexed citations
6.
Herold, Zoltán, et al.. (2023). Predicting Potentially Fatal COVID-19 Disease in Pregnant Patients Using the Neutrophil-to-Lymphocyte Ratio (NLR). Journal of Clinical Medicine. 12(21). 6896–6896. 1 indexed citations
7.
8.
Glasz, Tibor, Zoltán Herold, Gábor Tóth, et al.. (2023). Spatially Resolved Proteomic and Transcriptomic Profiling of Anaplastic Lymphoma Kinase-Rearranged Pulmonary Adenocarcinomas Reveals Key Players in Inter- and Intratumoral Heterogeneity. International Journal of Molecular Sciences. 24(14). 11369–11369. 3 indexed citations
9.
Szász, Attila Marcell, Giammaria Fiorentini, Magdolna Herold, et al.. (2023). Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas. Cancers. 15(3). 880–880. 5 indexed citations
10.
Dank, Magdolna, Magdolna Herold, Zoltán Herold, et al.. (2023). Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases. World Journal of Gastroenterology. 29(18). 2850–2863. 2 indexed citations
11.
Herold, Zoltán, Tamás Garay, Magdolna Herold, et al.. (2023). High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer. International Journal of Molecular Sciences. 24(18). 13684–13684. 3 indexed citations
12.
Somogyi, Anikó, Magdolna Herold, Klára Rosta, et al.. (2022). Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?. Open Medicine. 17(1). 160–173. 3 indexed citations
13.
Herold, Zoltán, Gábor Nyírő, Katalin Borka, et al.. (2022). Tissue miRNA Combinations for the Differential Diagnosis of Adrenocortical Carcinoma and Adenoma Established by Artificial Intelligence. Cancers. 14(4). 895–895. 12 indexed citations
14.
Doleschall, Márton, Zoltán Herold, Zoltán Doleschall, et al.. (2022). Quantitative PCR from human genomic DNA: The determination of gene copy numbers for congenital adrenal hyperplasia and RCCX copy number variation. PLoS ONE. 17(12). e0277299–e0277299. 2 indexed citations
15.
Herold, Zoltán, et al.. (2022). Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer. World Journal of Clinical Cases. 10(20). 6825–6844. 6 indexed citations
16.
Herold, Zoltán, et al.. (2022). High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancer. World Journal of Clinical Cases. 10(13). 4084–4096. 8 indexed citations
17.
Herold, Zoltán, Márton Doleschall, & Anikó Somogyi. (2021). Role and function of granin proteins in diabetes mellitus. World Journal of Diabetes. 12(7). 1081–1092. 6 indexed citations
18.
Molnár, Zsuzsanna, Zsófia Bánlaki, Anikó Somogyi, et al.. (2020). Diabetes-specific Modulation of Peripheral Blood Gene Expression Signatures in Colorectal Cancer. Current Molecular Medicine. 20(10). 773–780. 6 indexed citations
19.
Herold, Zoltán, Magdolna Herold, Péter Nagy, et al.. (2019). Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin‐like cell hyperplasia and autoimmune gastritis. Journal of Diabetes Investigation. 11(4). 865–873. 12 indexed citations
20.
Herold, Zoltán, et al.. (2018). Chromogranina A i jej rola w patogenezie cukrzycy. Endokrynologia Polska. 69(5). 598–610. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jihye Kim Breakdown of academic impact, for papers by Isabel Anna Carota Breakdown of academic impact, for papers by Lijun Yang Breakdown of academic impact, for papers by Anna Synakiewicz Breakdown of academic impact, for papers by Yan‐Wen Shu Breakdown of academic impact, for papers by Quan Liu Breakdown of academic impact, for papers by Agathi Karakosta Breakdown of academic impact, for papers by David Cheung Breakdown of academic impact, for papers by Yanfei Ma Breakdown of academic impact, for papers by Lucas Bacmeister
Rankless by CCL
2026